4Sem.·

Eli Lilly
$LLY (-1,49 %) is about to receive approval from the Japanese 🇯🇵 government for the launch of its obesity drugs. obesity drugs reports Nikkei.

attachment
15
2 Commentaires

image de profil
However, anyone who has been to Japan knows that the country has few problems with obesity.
5
Afficher la réponse
Participez à la conversation